Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
about the author
Max Bayer
Pharma Reporter
mbayer@endpointsnews.com
author articles
Pfizer's former top executives pitched changes to board as part of activist's plan
9 months ago
People
Pharma
BARDA doles out $72M to Sanofi, GSK and CSL for bird flu vaccine supply
9 months ago
Pharma
FDA+
J&J discontinues mid-stage dengue study, citing deprioritization of communicable disease work
9 months ago
R&D
Pharma
Exclusive: Relay Therapeutics cuts another 10% of company, citing continued streamlining efforts
9 months ago
People
R&D
Wave’s new capital extends cash runway into 2027, CEO says
9 months ago
R&D
J&J and Bayer to lay off almost 300 staffers in New Jersey
9 months ago
People
Pharma
California's Gavin Newsom vetoes bipartisan PBM reform bill
9 months ago
Pharma
Kezar halts mid-stage lupus study after four deaths
9 months ago
R&D
Rivus details weight loss data in heart failure patients and preps for new fundraise
9 months ago
Startups
R&D
FDA lifts hold on Biomea’s diabetes trials
9 months ago
Pharma
FDA+
Exclusive: J&J folds cardiovascular and metabolic drug unit
9 months ago
R&D
Baltimore sues Biogen, saying the company colluded with PBMs to minimize generic competition
9 months ago
Pharma
Law
SIGA fires former NYC Covid advisor after secret recordings detail pandemic-era parties
9 months ago
People
Pharma
Wave rides new Phase 2 DMD data as it sets sights on accelerated approval
9 months ago
R&D
Sanofi's Sarclisa gets approved as a first-line option for some patients newly diagnosed with multiple myeloma
9 months ago
Pharma
FDA+
FDA OKs the first-ever self-administered vaccine, for flu
9 months ago
Pharma
FDA+
European regulators reaffirm Apellis’ rejection, add eight positive recommendations
9 months ago
FDA+
Aligos’ trial for oral MASH treatment succeeds, but placebo group shows odd trend
9 months ago
R&D
4DMT's gene therapy reduced need for standard-of-care injections to treat age-associated vision loss
9 months ago
R&D
Cell/Gene Tx
FDA rejects Vanda’s treatment for digestion condition, company rebukes agency's actions
9 months ago
Pharma
FDA+
FDA approves AstraZeneca’s asthma medication Fasenra to treat rare autoimmune condition
9 months ago
Pharma
FDA+
Keytruda adds new FDA approval for a rare form of mesothelioma
9 months ago
R&D
Pharma
Roivant makes another deal, selling Dermavant to Organon for up to $1.2B
9 months ago
Deals
Novo Nordisk signs genetic medicine pact, inking deal with NanoVation
9 months ago
Deals
First page
Previous page
7
8
9
10
11
12
13
Next page
Last page